RSquare BioLabs is a premier Contract Research Organization (CRO) delivering end-to-end testing, analytical profiling, and preclinical studies tailored for global biotech, pharmaceutical, and healthcare leaders.
Established in 2021, RSquare BioLabs strives to build long-term partnerships by providing professional, ethical, and customer-focused laboratory services.
To be a trusted center of excellence in analytical testing, scientific research, and laboratory services by delivering innovative, reliable, and high-quality solutions that support healthcare, life sciences, and industrial advancement.
RSquare BioLabs maintains stringently audited quality systems that conform to national and international regulatory requirements. Our data packages are prepared to support regulatory filings across CDSCO, DCA, NABL ISO 17025, and GLP standards.
Every analytical study conducted at Rsquare Biolabs comes with comprehensive Documentation of Analysis (COA) backed by raw audit data.
Navigating complex international regulatory frameworks with specialized analytical documentation.
Compilation of Module 3 CTD data, stability data packages, and analytical validation reports for filing.
Direct scientific consultation to clarify and defend analytical study data during health authority audits.
Seamless technology and method transfer protocols between client laboratories and Rsquare testing sites.
We actively collaborate with universities, research institutions, and postgraduate scholars to provide access to high-end analytical instrumentation, cell culture facilities, and preclinical research guidance.
Instrumental analysis (HPLC, LC-MS, FTIR) for academic dissertation projects.
Practical workshops on bio-analytical techniques and cell culture assays.
Discuss your analytical, microbiological, or preclinical testing needs with our scientists today. We guarantee rapid turnaround times without compromising accuracy.